Michael R Carruthers

Affiliations

  • at Elevation Oncology Inc. (ELEV), 2025-06-09
  • at Onkure Therapeutics Inc. (OKUR), 2025-05-30
  • Chief Financial Officer at Edgewise Therapeutics Inc. (EWTX), 2025-05-08
  • Chief Financial Officer at Brickell Biotech Inc. (BBI), 2020-03-18
  • Interim President / Cfo at Nivalis Therapeutics Inc. (NVLS), 2017-01-23
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NVLS $2.09 24,000 $50,256.00 24,000 2016-12-02 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EWTX $16.45 1,314 $21,620.82 81,014 2025-05-02 Filing
EWTX $28.55 50,000 $1,427,385.00 6,904 2024-09-20 Filing
EWTX $28.59 24,960 $713,511.55 6,904 2024-09-20 Filing
EWTX $28.59 4,064 $116,174.32 31,864 2024-09-20 Filing
EWTX $28.59 46,068 $1,316,909.06 35,928 2024-09-20 Filing